CD34 and Scheie syndrome: Sub-lethal irradiation and busulfan-mediated myeloablation are standard protocols for conditioning before HSCT [15,20,81], and their effectiveness in enhancing the engraftment of CRISPR/Cas9-modified human CD34+ cells was assessed by Poletto et al. (2022) in MPS I mice.